EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 20 (2013) Parasite, 20 (2013) 44 References
Open Access
Issue
Parasite
Volume 20, 2013
Article Number 44
Number of page(s) 7
DOI https://doi.org/10.1051/parasite/2013044
Published online 14 November 2013
  1. Afonso E, Thulliez P, Gilot-Fromont E. 2010. Local meteorological conditions, dynamics of seroconversion to Toxoplasma gondii in cats (Felis catus) and oocyst burden in a rural environment. Epidemiology and Infection, 138, 1105–1113. [CrossRef] [PubMed] [Google Scholar]
  2. Basu S, Das T, Biswas G. 2010. Bilateral toxoplasma retinochoroiditis in a patient with chronic myeloid leukemia treated with imatinib mesylate. Ocular Immunology and Inflammation, 18, 64–65. [CrossRef] [PubMed] [Google Scholar]
  3. Bottós J, Miller RH, Belfort RN, Macedo AC, UNIFESP Toxoplasmosis Group, Belfort R Jr, Grigg ME. 2009. Bilateral retinochoroiditis caused by an atypical strain of Toxoplasma gondii. British Journal of Ophthalmology, 93, 1546–1550. [CrossRef] [Google Scholar]
  4. Chen Y, Inobe J, Marks R, Gonnella P, Kuchroo VK, Weiner HL. 1995. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature, 376, 177–180. [CrossRef] [PubMed] [Google Scholar]
  5. Del Vado G. 1997. Congenital toxoplasmosis in South American children. Archivos Argentinos de Pediatria, 95, 14–20. [Google Scholar]
  6. Dubey JP, Frenkel JK. 1972. Cyst induced toxoplasmosis in cats. Journal of Protozoology, 19, 155–177. [CrossRef] [Google Scholar]
  7. Dubey JP. 1998. Toxoplasma gondii oocyst survival under defined temperatures. Journal of Parasitology, 84, 862–865. [CrossRef] [Google Scholar]
  8. Durlach R, Kaufer F, Carral L, Freuler C, Ceriotto M, Rodriguez M, Freilij H, Altech J, Vazquez L, Corazza R, Maria Dalla Fontana, Arienti H, Sturba E, Gonzalez Ayala S, Cecchini E, Salomon C, Nadal M, Gutierrez N, Guarnera E. 2008. Consenso Argentino de Toxoplasmosis Congénita. Medicina (Buenos Aires), 68, 75–87. [Google Scholar]
  9. Echavarría M, Querci M, Marcone D, Videla C, Martinez A, Bonvehi P, Carballal G. 2010. Pandemic (H1N1) 2009 cases, Buenos Aires, Argentina. Emerging Infectious Diseases, 16, 311–313. [CrossRef] [PubMed] [Google Scholar]
  10. Elbez-Rubinstein A, Ajzenberg D, Dardé ML, Cohen R, Dumètre A, Yera H, Gondon E, Janaud JC, Thulliez P. 2009. Congenital toxoplasmosis and reinfection during pregnancy: case report, strain characterization, experimental model of reinfection, and review. Journal of Infectious Diseases, 199, 280–285. [CrossRef] [PubMed] [Google Scholar]
  11. Fabri M, Stenger S, Shin DM, Yuk JM, Liu PT, Realegeno S, Lee HM, Krutzik SR, Schenk M, Sieling PA, Teles R, Montoya D, Iyer SS, Bruns H, Lewinsohn DM, Hollis BW, Hewison M, Adams JS, Steinmeyer A, Zügel U, Cheng G, Jo EK, Bloom BR, Modlin RL. 2011. Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Science Translational Medicine, 3, 104ra102. [CrossRef] [PubMed] [Google Scholar]
  12. Fekkar A, Fekkar A, Ajzenberg D, Bodaghi B, Touafek F, Le Hoang P, Delmas J, Robert PY, Dardé ML, Mazier D, Paris L. 2011. Direct genotyping of Toxoplasma gondii in ocular fluid samples from 20 patients with oculartoxoplasmosis: predominance of type II in France. Journal of Clinical Microbiology, 49, 1513–1517. [CrossRef] [PubMed] [Google Scholar]
  13. Ferreira IM, Vidal JE, de Mattos Cde C, de Mattos LC, Qu D, Su C, Pereira-Chioccola VL. 2011. Toxoplasma gondii isolates: multilocus RFLP-PCR genotyping from human patients in Sao Paulo State, Brazil identified distinct genotypes. Experimental Parasitology, 129, 190–195. [CrossRef] [PubMed] [Google Scholar]
  14. Garweg JG, Candolfi E. 2009. Immunopathology in ocular toxoplasmosis: facts and clues. Memorias do Instituto Oswaldo Cruz, 104, 211–220. [CrossRef] [PubMed] [Google Scholar]
  15. Glasner PD, Silveira C, Kruszon-Moran D, Martins MC, Burnier Júnior M, Silveira S, Camargo ME, Nussenblatt RB, Kaslow RA, Belfort Júnior R. 1992. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. American Journal of Ophthalmology, 114, 136–144. [PubMed] [Google Scholar]
  16. Gilbert RE, Freeman K, Lago EG, Bahia-Oliveira LM, Tan HK, Wallon M, Buffolano W, Stanford MR, Petersen E, European Multicentre Study on Congenital Toxoplasmosis (EMSCOT). 2008. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Neglected Tropical Diseases, 2, e277. [CrossRef] [PubMed] [Google Scholar]
  17. Gomez-Marin JE. 2011. First Colombian multicentric newborn screening for congenital toxoplasmosis. PLoS Neglected Tropical Diseases, 5, e1195. [CrossRef] [PubMed] [Google Scholar]
  18. Holland GN, Engstrom RE Jr, Glasgow BJ, Berger BB, Daniels SA, Sidikaro Y, Harmon JA, Fischer DH, Boyer DS, Rao NA, Eagle RC Jr, Kreiger AE, Foos RY. 1988. Ocular toxoplasmosis in patients with acquired immunodeficiency syndrome. American Journal of Ophthalmology, 106, 653–667. [PubMed] [Google Scholar]
  19. Holland GN, O’Connor GR, Belfort R Jr. 1995. Toxoplasmosis ocular infection and immunity, Chapter 85. Pepose Jay S, Holland Gary N, Whilhelmus Kirk R (Eds.), 1183–1223, [Google Scholar]
  20. IBM Corp. Released. 2010. IBM SPSS Statistics for Windows, Version 19.0, Armonk, NY: IBM Corp. [Google Scholar]
  21. Khan A, Jordan C, Muccioli C, Vallochi AL, Rizzo LV, Belfort R Jr, Vitor RW, Silveira C, Sibley LD. 2006. Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil. Emerging Infectious Diseases, 12, 942–949. [CrossRef] [PubMed] [Google Scholar]
  22. Lélu M, Villena I, Dardé ML, Aubert D, Geers R, Dupuis E, Marnef F, Poulle ML, Gotteland C, Dumètre A, Gilot-Fromont E. 2012. Quantitative estimation of the viability of Toxoplasma gondii oocysts in soil. Applied Environmental Microbiology, 78, 5127–5132. [Google Scholar]
  23. Libster R, Bugna J, Coviello S, Hijano DR, Dunaiewsky M, Reynoso N, Cavalieri ML, Guglielmo MC, Areso MS, Gilligan T, Santucho F, Cabral G, Gregorio GL, Moreno R, Lutz MI, Panigasi AL, Saligari L, Caballero MT, Egües Almeida RM, Gutierrez Meyer ME, Neder MD, Davenport MC, Del Valle MP, Santidrian VS, Mosca G, Garcia Domínguez M, Alvarez L, Landa P, Pota A, Boloñati N, Dalamon R, Sanchez Mercol VI, Espinoza M, Peuchot JC, Karolinski A, Bruno M, Borsa A, Ferrero F, Bonina A, Ramonet M, Albano LC, Luedicke N, Alterman E, Savy V, Baumeister E, Chappell JD, Edwards KM, Melendi GA, Polack FP. 2010. Pedriatic hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. New England Journal of Medicine, 362, 45–55. [CrossRef] [Google Scholar]
  24. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zügel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL. 2006. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science, 311, 1770–1773. [CrossRef] [PubMed] [Google Scholar]
  25. Mele A, Paterson PJ, Prentice HG, Leoni P, Kibbler CC. 2002. Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone Marrow Transplantation, 29, 691–698. [CrossRef] [PubMed] [Google Scholar]
  26. Miyamoto C, Rubens Belfort M, Di Cesare S, Rubens Belfort J, Burnier MN Jr. 2010. Use of CD25 as an immunohistochemical marker for acquired toxoplasmosis. Arquivos Brasileiros de Oftalmologia, 73, 443–446. [CrossRef] [PubMed] [Google Scholar]
  27. Morin L, Lobry Jr, Peyron F, Wallon M. 2012. Seasonal variations in acute toxoplasmosis in pregnant women in the Rhone-Alpes region (France). Clinical Microbiology and Infection, 10, 401–403. [CrossRef] [Google Scholar]
  28. Nicolle C, Manceaux L. 1909. Sur un protozoaire nouveau du gondi. Comptes Rendus des Séances de l’Académie des Sciences, 148, 369–372. [Google Scholar]
  29. Oldenhove G, Bouladoux N, Wohlfert EA, Hall JA, Chou D, Dos Santos L, O’Brien S, Blank R, Lamb E, Natarajan S, Kastenmayer R, Hunter C, Grigg ME, Belkaid Y. 2009. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity, 31, 772–786. [CrossRef] [PubMed] [Google Scholar]
  30. Park KL, Smith RE, Rao NA. 1995. Ocular manifestations of AIDS. Current Opinion in Ophthalmology, 6, 82–87. [CrossRef] [PubMed] [Google Scholar]
  31. Portela ML, Mónico A, Barahona A, Dupraz H, Sol Gonzales-Chaves MM, Zeni S. 2010. Comparative 25-OH-vitamin D level in institutionalized women older than 65 years from two cities in Spain and Argentina having a similar solar radiation index. Nutrition, 26, 283–289. [CrossRef] [PubMed] [Google Scholar]
  32. Rajapakse R, Uring-Lambert B, Andarawewa KL, Rajapakse RP, Abou-Bacar A, Marcellin L, Candolfi E. 2007. 1,25(OH)2D3 inhibits in vitro and in vivo intracellular growth of apicomplexan parasite Toxoplasma gondii. Journal of Steroid Biochemistry, 103, 811–814. [CrossRef] [Google Scholar]
  33. Rudzinski M, Meyer A. 2011. Prevalence and risk factors associated with ocular toxoplasmosis in patients from the center east region of the province of Misiones, Argentina. Oftalmología Clínica y Experimental, 4, 159–162. [Google Scholar]
  34. Singh S, Pandit AJ. 2004. Incidence and prevalence of toxoplasmosis in Indian pregnant women: a prospective study. American Journal of Reproductive Immunology, 52, 276–283. [CrossRef] [Google Scholar]
  35. Sroka S, Bartelheimer N, Winter A, Heukelbach J, Ariza L, Ribeiro H, Oliveira FA, Queiroz AJ, Alencar C Jr, Liesenfeld O. 2010. Prevalence and risk factors of toxoplasmosis among pregnant women in Fortaleza, North-eastern Brazil. American Journal of Tropical Medicine and Hygiene, 83, 528–533. [CrossRef] [Google Scholar]
  36. Stanford M, Whittal T, Bergmeier LA, Lindbland M, Lundin S, Shinnick T, Mizushima Y, Holmgren J, Lehner T. 2004. Oral tolerization with peptide 336–51 link to cholera toxin B in preventing relapses of uveitis in Behcet’s disease. Clinical and Experimental Immunology, 137, 201–208. [CrossRef] [PubMed] [Google Scholar]
  37. Theaudin M, Bodaghi B, Cassoux N, Romand S, Le Mer Y, Lemaitre C, Fardeau C, Thulliez P, LeHoang P. 2003. Extensive toxoplasmic retinochoroiditis. Diagnostic and therapeutic management. Journal Français d’Ophtalmologie, 26, 921–927. [Google Scholar]
  38. Thorstenson KM, Khoruts A. 2001. Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. Journal of Immunology, 167, 188–195. [Google Scholar]
  39. Van Wilsem EJ, Van Hoogstraten IM, Brevé J, Scheper RJ, Kraal G. 1994. Dendritic cells of the oral mucosa and the induction of oral tolerance. A local affair. Immunology, 83, 128–132. [PubMed] [Google Scholar]
  40. Varella IS, Canti IC, Santos BR, Coppini AZ, Argondizzo LC, Tonin C, Wagner MB. 2009. Prevalence of acute Toxoplasma gondii infection among 41112 pregnant women and the mother to child transmission rate in a public hospital in south Brazil. Memorias do Instituto Oswaldo Cruz, 104, 383–388. [CrossRef] [PubMed] [Google Scholar]
  41. Vaz RS, Thomaz-Soccol V, Sumikawa E, Guimaraes AT. 2010. Serologic prevalence of Toxoplasma gondii antibodies in pregnant women of southern Brazil. Parasitology Research, 106, 661–665. [CrossRef] [PubMed] [Google Scholar]
  42. Weiner HL. 2001. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunological Reviews, 182, 207–214. [CrossRef] [PubMed] [Google Scholar]
  43. Wohlfert E, Belkaid Y. 2010. Plasticity of T reg at infected sites. Mucosal Immunology, 3, 213–215. [CrossRef] [PubMed] [Google Scholar]
  44. Zhang X, Izikson L, Liu L, Weiner HL. 2001. Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration. Journal of Immunology, 167, 4245–4253. [Google Scholar]
  45. Zemene E, Yewhalaw D, Abera S, Belay T, Samuel A, Zeynudin A. 2012. Seroprevalence of Toxoplasma gondii and associated risk factors among pregnant women in Jimma town, Southwestern Ethiopia. BMC Infectious Diseases, 12, 337. DOI:10.1186/1471-2334-12-337. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.